Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopic Mucosal Resection | 12 | 2024 | 74 | 2.650 |
Why?
|
| Capsule Endoscopy | 5 | 2021 | 20 | 1.820 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2021 | 223 | 1.420 |
Why?
|
| Esophageal Neoplasms | 6 | 2024 | 359 | 1.100 |
Why?
|
| Colonic Polyps | 3 | 2024 | 78 | 1.040 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2024 | 243 | 0.990 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 300 | 0.820 |
Why?
|
| Feasibility Studies | 1 | 2024 | 756 | 0.750 |
Why?
|
| Colonoscopy | 4 | 2024 | 239 | 0.740 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 83 | 0.680 |
Why?
|
| Colon | 1 | 2022 | 352 | 0.670 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 30 | 0.650 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 240 | 0.640 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2019 | 34 | 0.640 |
Why?
|
| Hematemesis | 1 | 2018 | 6 | 0.620 |
Why?
|
| Pancreas | 1 | 2019 | 211 | 0.620 |
Why?
|
| Endoscopy, Digestive System | 2 | 2018 | 153 | 0.600 |
Why?
|
| Pancreatitis | 1 | 2019 | 129 | 0.590 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 676 | 0.580 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 120 | 0.550 |
Why?
|
| Colorectal Neoplasms | 4 | 2024 | 561 | 0.540 |
Why?
|
| Myotomy | 3 | 2024 | 18 | 0.500 |
Why?
|
| Operative Time | 3 | 2024 | 161 | 0.490 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 651 | 0.450 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 993 | 0.370 |
Why?
|
| Prospective Studies | 9 | 2024 | 6029 | 0.360 |
Why?
|
| Aged | 14 | 2024 | 19108 | 0.350 |
Why?
|
| Natural Orifice Endoscopic Surgery | 4 | 2024 | 70 | 0.350 |
Why?
|
| Gastroenterology | 2 | 2024 | 191 | 0.340 |
Why?
|
| Neoplasm, Residual | 3 | 2024 | 121 | 0.310 |
Why?
|
| Humans | 30 | 2024 | 123180 | 0.300 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 208 | 0.290 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2024 | 79 | 0.280 |
Why?
|
| Barrett Esophagus | 2 | 2021 | 340 | 0.280 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 6375 | 0.270 |
Why?
|
| Middle Aged | 13 | 2024 | 26015 | 0.270 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12142 | 0.270 |
Why?
|
| Esophageal Achalasia | 2 | 2024 | 37 | 0.270 |
Why?
|
| Male | 17 | 2024 | 60173 | 0.250 |
Why?
|
| Gastroenterologists | 1 | 2024 | 11 | 0.230 |
Why?
|
| Intestinal Polyps | 1 | 2024 | 29 | 0.230 |
Why?
|
| Standard of Care | 3 | 2019 | 129 | 0.230 |
Why?
|
| Electrosurgery | 1 | 2024 | 19 | 0.230 |
Why?
|
| Esophageal Motility Disorders | 1 | 2024 | 13 | 0.230 |
Why?
|
| Gels | 1 | 2024 | 60 | 0.220 |
Why?
|
| Esophageal Stenosis | 1 | 2024 | 44 | 0.220 |
Why?
|
| Fundoplication | 1 | 2024 | 66 | 0.220 |
Why?
|
| Oncolytic Viruses | 1 | 2024 | 71 | 0.210 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 235 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 203 | 0.210 |
Why?
|
| Mentoring | 1 | 2024 | 75 | 0.210 |
Why?
|
| Propensity Score | 1 | 2024 | 212 | 0.210 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2023 | 83 | 0.210 |
Why?
|
| Retrospective Studies | 12 | 2024 | 16062 | 0.200 |
Why?
|
| Postoperative Care | 1 | 2024 | 295 | 0.200 |
Why?
|
| Anemia | 2 | 2024 | 340 | 0.200 |
Why?
|
| Equipment Design | 1 | 2024 | 604 | 0.200 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 228 | 0.200 |
Why?
|
| Female | 15 | 2024 | 65562 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 290 | 0.180 |
Why?
|
| Cytodiagnosis | 1 | 2020 | 19 | 0.180 |
Why?
|
| Bile Ducts | 1 | 2020 | 54 | 0.170 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 80 | 0.170 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 12 | 0.170 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2019 | 25 | 0.160 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 109 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 164 | 0.160 |
Why?
|
| Endosonography | 1 | 2019 | 81 | 0.160 |
Why?
|
| Intestine, Small | 1 | 2021 | 302 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 501 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 56 | 0.150 |
Why?
|
| Diabetes Complications | 1 | 2019 | 196 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 257 | 0.140 |
Why?
|
| Acute Disease | 1 | 2019 | 1093 | 0.130 |
Why?
|
| Adult | 5 | 2024 | 29032 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3015 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 899 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1924 | 0.110 |
Why?
|
| Length of Stay | 1 | 2019 | 1288 | 0.110 |
Why?
|
| Esophagoscopy | 2 | 2024 | 156 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 6221 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 848 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 1118 | 0.090 |
Why?
|
| United States | 3 | 2024 | 10660 | 0.090 |
Why?
|
| Young Adult | 2 | 2020 | 8864 | 0.080 |
Why?
|
| Risk Factors | 2 | 2024 | 10031 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3547 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 771 | 0.070 |
Why?
|
| Margins of Excision | 1 | 2024 | 51 | 0.060 |
Why?
|
| North America | 1 | 2024 | 239 | 0.060 |
Why?
|
| Albumins | 1 | 2024 | 88 | 0.060 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2023 | 11 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2024 | 120 | 0.050 |
Why?
|
| Surgical Instruments | 1 | 2023 | 56 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 280 | 0.050 |
Why?
|
| Rectum | 1 | 2023 | 97 | 0.050 |
Why?
|
| Sutures | 1 | 2022 | 67 | 0.050 |
Why?
|
| Brazil | 1 | 2022 | 120 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 255 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 608 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2024 | 485 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 257 | 0.040 |
Why?
|
| Peptides | 1 | 2024 | 792 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2020 | 23 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 533 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 53 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 295 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2021 | 331 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2020 | 54 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 458 | 0.040 |
Why?
|
| Professional Practice | 1 | 2019 | 42 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2024 | 678 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1389 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 402 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 240 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 107 | 0.040 |
Why?
|
| Melena | 1 | 2018 | 5 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 284 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 538 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 179 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1232 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 1236 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2840 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 517 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1006 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2011 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1305 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1415 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3670 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2020 | 973 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1800 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 4703 | 0.030 |
Why?
|
| Adolescent | 1 | 2020 | 19111 | 0.010 |
Why?
|
| Child | 1 | 2020 | 24247 | 0.010 |
Why?
|